FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Salicylic acid 12% collodion (J M Loveridge Plc) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nurofen Express (ibuprofen sodium dihydrate) 200mg caplets (Reckitt Benckiser Plc) 16 tablet 2 x 8 tablets (product) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 12% collodion (Unichem Plc) 500 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (Thornton & Ross Ltd) 200 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nurofen Express (ibuprofen sodium dihydrate) 200mg caplets (Reckitt Benckiser Plc) 12 tablet 2 x 6 tablets (product) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Credalast Circular Knit (one way stretch) class III cotton kneecap made to measure Beige (Credenhill Ltd) 2 stocking VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 50% ointment (A A H Pharmaceuticals Ltd) 500 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 12% collodion (J M Loveridge Plc) 500 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Methyl salicylate 25% liniment (A A H Pharmaceuticals Ltd) 500 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
AquaBar (Co-Pharma Ltd) 100 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely dicycloverine hydrochloride 2 milligram/1 milliliter conventional release oral solution VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Merbentyl 10mg/5ml syrup (Florizel Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Merbentyl 10mg/5ml syrup (Florizel Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Zentiva Pharma UK Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 5cm x 7.5cm (B.Braun Medical Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely dicycloverine hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely dicycloverine hydrochloride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg rectal foam VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Predfoam 20mg/application enema (Forest Laboratories UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Merbentyl 20 tablets (Florizel Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (Essential Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema 14 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Merbentyl 10mg tablets (Florizel Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Merbentyl 10mg tablets (Florizel Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Merbentyl 20 tablets (Florizel Ltd) 84 tablet 4 x 21 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Zentiva Pharma UK Ltd) 84 tablet 4 x 21 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (Essential Generics Ltd) 14 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Predfoam 20mg/application enema (Forest Laboratories UK Ltd) 14 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely clomethiazole 192 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heminevrin 192mg capsules (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 192mg capsules 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heminevrin 192mg capsules (AstraZeneca) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 192mg capsules (Neon Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 192mg capsules (Neon Healthcare Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heminevrin 192mg capsules (AstraZeneca) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heminevrin 192mg capsules (PI) (Waymade Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Alliance Healthcare (Distribution) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (Alliance Healthcare (Distribution) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Alliance Healthcare (Distribution) Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Alliance Healthcare (Distribution) Ltd) 84 tablet 4 x 21 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (A A H Pharmaceuticals Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (A A H Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (A A H Pharmaceuticals Ltd) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Argipressin 20units/1ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Argipressin 20units/1ml solution for injection ampoules 20 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Argipressin 20units/1ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) 20 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 5 milligram/1 gram conventional release cutaneous gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 0.5% gel 135 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 0.5% gel 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 0.5% gel (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) 135 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 0.5% gel (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1mL injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emozul 40mg gastro-resistant capsules (Krka UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emozul 20mg gastro-resistant capsules (Krka UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aramine 10mg/1ml solution for injection ampoules (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aramine 10mg/1ml solution for injection ampoules (Organon Pharma (UK) Ltd) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emozul 40mg gastro-resistant capsules (Krka UK Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Viatris UK Healthcare Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Viatris UK Healthcare Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Emozul 20mg gastro-resistant capsules (Krka UK Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 192mg capsules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 192mg capsules (A A H Pharmaceuticals Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 10g/100ml solution for infusion bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 5g/50ml solution for infusion bottles VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 5g/50ml solution for infusion bottles 1 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 10g/100ml solution for infusion bottles 1 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Octagam 10g/100ml solution for infusion bottles (Octapharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Octagam 5g/50ml solution for infusion bottles (Octapharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Octagam 10g/100ml solution for infusion bottles (Octapharma Ltd) 1 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Octagam 5g/50ml solution for infusion bottles (Octapharma Ltd) 1 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use 1.8mm/26gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use 2.4mm/21gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Apollo pressure-activated safety lancets 2.4mm/21gauge (Apollo Medical Technologies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
VitalCare AUTO Junior lancets 1.8mm/26gauge Pink (VitalCare (UK)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 46 of 86 Next End


This concept is not in any reference sets

Back to Start